Lo Andrew — SEC Form 4 filings
SEC reporting owner CIK 1679076. 7 Form 4 filings on record with FilingPulse; latest filed 2026-06-24.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-06-24 to 2026-06-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 2 filings — 195,599 shares, $10,169,562 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 100,000 shares @ $38.50 ($3,849,900) in BridgeBio Pharma, Inc., filed 2025-05-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | Director | 5 | — | 5 legs · 195,599 sh · $10,169,562 | 5 |
| AbCellera Biologics Inc. (ABCL) | Director | 2 | — | — | 2 |
Form 4 filings — Lo Andrew
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-24 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 3,990 @ $0 · Grant/award (A): 5,277 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 36,801 @ $66.63 · Sale (S): 3,798 @ $67.06 · Sale (S): 24,007 @ $65.23 · Sale (S): 30,993 @ $66.05 | EDGAR |
| 2025-06-24 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 6,589 @ $0 · Grant/award (A): 8,425 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | AbCellera Biologics Inc. (ABCL) | Grant/award (A): 238,864 (derivative) @ $0 | EDGAR |
| 2025-05-06 | 4 | BridgeBio Pharma, Inc. (BBIO) | Sale (S): 100,000 @ $38.50 | EDGAR |
| 2024-06-25 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 26,014 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | AbCellera Biologics Inc. (ABCL) | Grant/award (A): 163,934 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1679076 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →